Robert L. Murphy

Q: What Schools Are Affiliated With Robert L. Murphy

Robert L. Murphy is affiliated with the following schools: Boston University, Northwestern University , Northwestern University, Stanford University, University of Chicago, Johns Hopkins University, Sorbonne University

Robert L. Murphy's AcademicInfluence.com Rankings

Robert L. Murphy

Philosophy

#8876

World Rank

#12339

Historical Rank

#1732

USA Rank

Logic

#5888

World Rank

#7336

Historical Rank

#913

USA Rank

philosophy Degrees

Download Badge

Philosophy

Robert L. Murphy's Degrees

Doctorate Medicine Johns Hopkins University
Masters Public Health Johns Hopkins University

Why Is Robert L. Murphy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Robert Leo Murphy is an American infectious disease physician and professor of medicine. He is the John Philip Phair Professor of Infectious Diseases at Northwestern University where he serves as executive director of the Institute for Global Health and the Center for Global Communicable Diseases. Murphy earned a MD at the Stritch School of Medicine in 1978. He completed a medical residency and fellowship at Northwestern Memorial Hospital.

(See a Problem?)

Robert L. Murphy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study (2004) (734)
Class-sparing regimens for initial treatment of HIV-1 infection. (2008) (701)
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. (2004) (536)
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. (2003) (357)
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. (1995) (313)
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. (2008) (312)
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile (2001) (289)
Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1 (2004) (282)
Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. (1992) (257)
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results (2001) (252)
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. (2009) (238)
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. (2006) (235)
Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results (2003) (226)
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. (1999) (208)
The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. (2002) (194)
Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. (1997) (191)
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients (2003) (190)
Visual lung-sound characterization by time-expanded wave-form analysis. (1977) (189)
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. (2000) (183)
Prevention of Relapse of Histoplasmosis with Itraconazole in Patients with the Acquired Immunodeficiency Syndrome (1993) (183)
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. (2011) (173)
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. (1998) (166)
Genetic and Functional Analysis of Full-Length Human Immunodeficiency Virus Type 1 env Genes Derived from Brain and Blood of Patients with AIDS (2003) (160)
The history of antiretroviral therapy and of its implementation in resource-limited areas of the world (2012) (155)
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients. (2002) (153)
A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy (2003) (151)
Telediagnosis: a new community health resource. Observations on the feasibility of telediagnosis based on 1000 patient transactions. (1974) (147)
Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. (2011) (146)
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. (2002) (144)
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. (2008) (142)
Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical use (1996) (130)
Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1. (1999) (125)
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study (2004) (123)
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials (2002) (120)
Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. (2009) (119)
Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis (2017) (119)
Automated lung sound analysis in patients with pneumonia. (2004) (117)
Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. (2015) (115)
Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral TherapyInduced Increases in CD4+ Cell Count (2000) (111)
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. (2010) (111)
Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir (2004) (111)
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. (2015) (105)
Effects of low concentrations of asbestos. Clinical, environmental, radiologic and epidemiologic observations in shipyard pipe coverers and controls. (1971) (92)
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452) (2008) (92)
Antiretroviral Durability and Tolerability in HIV-Infected Adults Living in Urban Kenya (2007) (88)
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: Selection of thymidine analog regimen therapy (START II)* (2000) (88)
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. (2005) (86)
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. (1999) (83)
Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. (1993) (82)
Clinical Efficacy of Monotherapy with Stavudine Compared with Zidovudine in HIV-Infected, Zidovudine-Experienced Patients (1997) (79)
Mechanism of inspiratory and expiratory crackles. (2009) (79)
Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection. (1988) (75)
Assessing the Viorologic and Adherence Benefits of Patient-Selected HIV Treatment Partners in a Resource-limited Setting (2009) (73)
Seven-Year Efficacy of a Lopinavir/Ritonavir-Based Regimen in Antiretroviral—Naïve HIV-1-Infected Patients (2008) (71)
International Symposium on Lung Sounds. Synopsis of proceedings. (1987) (71)
Dolutegravir for the treatment of HIV (2012) (71)
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850). (2000) (70)
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness (2015) (69)
Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. (2002) (67)
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362 (2011) (65)
Accuracy of dermatologic diagnosis by television. (1972) (63)
Validation of an automatic crackle (rale) counter. (1989) (59)
Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine (1995) (58)
Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy. (2011) (57)
Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome. (1990) (57)
The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy. (2000) (57)
Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. (2012) (56)
Clinical and Genotypic Findings in HIV-Infected Patients With the K65R Mutation Failing First-Line Antiretroviral Therapy in Nigeria (2009) (56)
Transient viremia in HIV-infected patients and use of plasma preparation tubes. (2005) (56)
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators. (1999) (54)
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (1997) (54)
Alternating and Intermittent Regimens of Zidovudine and Dideoxycytidine in Patients with AIDS or AIDS-Related Complex (1993) (54)
Acute respiratory effects in workers exposed to low levels of toluene diisocyanate (TDI). (1968) (54)
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial (2016) (53)
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. (2000) (53)
Respiratory impairment in workers exposed to "safe" levels of toluene diisocyanate (TDI). (1970) (52)
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes (2009) (52)
Incidence of Pancreatitis in HIV-1-Infected Individuals Enrolled in 20 Adult AIDS Clinical Trials Group Studies: Lessons Learned (2005) (52)
Clinical utility of chest auscultation in common pulmonary diseases. (1994) (52)
The pavia consensus statement. (2003) (51)
Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. (2000) (50)
Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. (1991) (49)
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection (2013) (49)
Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy (2010) (48)
Switch studies: a review (2002) (47)
Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy–Naive HIV-1–Infected Individuals (2013) (46)
Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment. (2013) (46)
Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen. (2009) (45)
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044. (1994) (45)
Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3 (2007) (44)
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment. (2007) (44)
Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults. (2011) (44)
Interferon-Alpha Administration Enhances CD8+ T Cell Activation in HIV Infection (2012) (44)
Low-Dose Daily Subcutaneous Interleukin-2 in Combination with Highly Active Antiretroviral Therapy in HIV + Patients: A Randomized Controlled Trial (2000) (43)
Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: The foscarnet-ganciclovir cytomegalovirus retinitis trial (1997) (43)
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine (2011) (43)
Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection. (1990) (43)
Lung sound nomenclature survey. (1990) (42)
Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. (1992) (42)
Absence of respiratory effects in subjects exposed to low concentrations of TDI and MDI. (1982) (41)
Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: The cytomegalovirus retreatment trial (1996) (41)
A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings (2011) (41)
Auscultation of the lung: past lessons, future possibilities. (1981) (40)
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850). (2002) (40)
Pulmonary Function in Shipyard Welders (1973) (39)
Signs and symptoms of “asymptomatic” hiv-1 infection in homosexual men (1993) (38)
An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1. (1995) (37)
Computerized multichannel lung sound analysis. Development of acoustic instruments for diagnosis and management of medical conditions. (2007) (37)
The prevalence and character of crackles (rales) in young women without significant lung disease. (2015) (36)
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients (2002) (36)
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l (2001) (36)
Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. (2011) (36)
Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali✩ (2019) (35)
Crackles in the early detection of asbestosis. (1984) (35)
Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes (2009) (34)
Cervical cancer survival in a resource-limited setting-North Central Nigeria (2016) (34)
Transmission of crackles in patients with interstitial pulmonary fibrosis, congestive heart failure, and pneumonia. (2005) (34)
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting. (2012) (33)
Chest auscultation in the diagnosis of pulmonary asbestosis. (1973) (33)
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. (2008) (32)
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients (2008) (32)
Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. (2004) (31)
Typhlitis in patients with HIV-1 infection. (1992) (31)
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial. (2015) (31)
Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection (2010) (31)
Defining the Toxicity Profile of Nevirapine and Other Antiretroviral Drugs (2003) (31)
Nonnucleoside reverse transcriptase inhibitors. (1997) (30)
Novel approaches to three drug antiretroviral therapy for HIV infection in 1997 (1997) (30)
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy (2020) (29)
Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection (2005) (29)
Accuracy of cardiac auscultation by microwave. (1973) (29)
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. (2009) (29)
Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria. (2013) (28)
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma (2019) (28)
Presence of HIV-1 R5 Viruses in Cerebrospinal Fluid Even in Patients Harboring R5X4/X4 Viruses in Plasma (2009) (28)
Acute pancreatitis associated with aerosolized pentamidine. (1990) (28)
In defense of the stethoscope. (2008) (27)
Safety , Tolerability , and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2 a in HIV-1 – Monoinfected Participants : A Phase II Clinical Trial (2010) (27)
Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. (1991) (26)
The efficacy of smoking cessation interventions in low‐ and middle‐income countries: a systematic review and meta‐analysis (2019) (26)
Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy (2001) (26)
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. (1999) (26)
Microwave transmission of chest roentgenograms. (1970) (26)
Ventilatory function in workers exposed to low levels of toluene diisocyanate: a six-month follow-up (1969) (26)
Low exposure to asbestos. Gas exchange in ship pipe coverers and controls. (1972) (26)
Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection (2012) (25)
Discontinuous Adventitious Lung Sounds (1985) (25)
Observer agreement, chest auscultation, and crackles in asbestos-exposed workers. (1986) (25)
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a. (2012) (24)
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. (1991) (24)
The progression of untreated HIV-1 infection prior to AIDS. (1992) (24)
HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study (2014) (24)
Triple nucleoside analogue vs. efavirenz-containing regimens for the initialtreatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095 (2004) (24)
Prevalence of chronic respiratory disease. Asbestosis in ship repair workers. (1971) (23)
Fansidar and hepatic granulomas. (1985) (23)
Phase II dose‐ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093) (1994) (23)
Predictors of outcome in AIDS patients receiving zidovudine. (1989) (22)
Has Omicron Changed the Evolution of the Pandemic? (2021) (22)
Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. (2013) (21)
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali (2019) (21)
Quantification of human immunodeficiency virus type 1 tat mRNA as a marker for assessing the efficacy of antiretroviral therapy. (1993) (21)
Individualized antiretroviral therapeutic approaches: less can be more (2017) (21)
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome. (1992) (21)
Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study (2017) (21)
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali (2017) (20)
Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression (2016) (20)
Extended antiretroviral treatment interruption in HIV‐infected patients with long‐term suppression of plasma HIV RNA (2005) (20)
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370 (2000) (20)
Increased cardiovascular risk in HIV infection: drugs, virus and immunity. (2008) (20)
Hepatoxicity in the U.S. Adult AIDS Clinical Trial Group (2001) (19)
Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. (2010) (19)
Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. (2014) (19)
Switching to darunavir/ritonavir 800/100 mg once‐daily containing regimen maintains virological control in fully suppressed pre‐treated patients infected with HIV‐1 (2013) (19)
Adherence to antiretroviral therapy in resource-limited settings: everything matters. (2007) (19)
Clinical applications and availability of CD4+ T cell count testing in sub‐Saharan Africa (2008) (18)
Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria—Implications for Care (2015) (18)
Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study. (2010) (18)
Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali. (2013) (18)
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study (2008) (18)
Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study (2020) (18)
Antiretroviral therapy for advanced naïve HIV-infected patients: current status and comparison of two different management strategies. (2007) (18)
Pulmonary toxicity of isocyanates. (1970) (17)
Hazards to health: do it yourself polyurethane foam. (2015) (17)
High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria (2013) (17)
Simultaneous diagnosis of tuberculous and non-tuberculous mycobacterial diseases: Time for a better patient management. (2018) (17)
Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection (2009) (17)
Chicago Medical Response to the 2010 Earthquake in Haiti: Translating Academic Collaboration Into Direct Humanitarian Response (2010) (17)
Evaluating therapeutic vaccines in patients infected with HIV (2004) (17)
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV (2010) (16)
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373. (2001) (16)
Crackle Pitch and Rate Do Not Vary Significantly During a Single Automated-Auscultation Session in Patients With Pneumonia, Congestive Heart Failure, or Interstitial Pulmonary Fibrosis (2011) (16)
Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study (2017) (16)
Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis. (1994) (16)
Stability of HIV RNA in plasma specimens stored at different temperatures (2008) (16)
Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. (2014) (16)
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort (2015) (15)
Surveillance of the Second Wave of COVID-19 in Europe: Longitudinal Trend Analyses (2020) (15)
Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults (2012) (15)
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy (2015) (15)
Comparison of Rapid Antigen Tests' Performance between Delta (B.1.61.7; AY.X) and Omicron (B.1.1.529; BA1) Variants of SARS-CoV-2: Secondary Analysis from a Serial Home Self-Testing Study (2022) (15)
Nontuberculous Mycobacteria Isolated from Tuberculosis Suspects in Ibadan, Nigeria (2016) (15)
Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients (2005) (15)
Serologic response in blastomycosis: diagnostic value of double immunodiffusion assay. (1981) (15)
Improvement in lipid profiles over 6 years of follow‐up in adults with AIDS and immune reconstitution (2009) (14)
miRNA-Processing Gene Methylation and Cancer Risk (2018) (14)
Potent Antiviral Effect of Reverset™ in HIV-1-Infected Adults following a Single Oral Dose (2003) (14)
Management of antiretroviral failure and resistance in developing countries (2009) (14)
The most frequent Mycobacterium tuberculosis complex families in mali (2006–2016) based on spoligotyping (2017) (14)
Impact of Hepatitis C Virus on HIV Response to Antiretroviral Therapy in Nigeria (2013) (14)
Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study. (2005) (14)
Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014 (2016) (14)
Pendelluft in Chronic Obstructive Lung Disease Measured with Lung Sounds (2012) (14)
Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program (2017) (14)
The AIDS Autopsy Spleen: A Comparison of the Pre-Anti-Retroviral and Highly Active Anti-Retroviral Therapy Eras (2002) (14)
Perspectives for immunotherapy: which applications might achieve an HIV functional cure? (2016) (13)
Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis (2018) (13)
Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali. (2021) (13)
Mycobacterium tuberculosis and Mycobacterium africanum in stools from children attending an immunization clinic in Ibadan, Nigeria. (2009) (13)
Crackle Pitch Rises Progressively during Inspiration in Pneumonia, CHF, and IPF Patients (2012) (12)
Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals (2010) (12)
Isolation of HIV-1 from monocytes of individuals negative by conventional culture. (1990) (12)
Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co‐infected Nigerians (2017) (12)
Validation of an Automatic Crackle ( Rale ) Counter 1 , 2 (2001) (12)
The RADx Tech Clinical Studies Core: A Model for Academic Based Clinical Studies (2021) (12)
Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature (2018) (12)
Point-of-Care Technology Research Network: An evolving model for collaborative translational research in biomedical engineering. (2019) (12)
Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota (2020) (12)
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group. (2000) (12)
Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. (2017) (11)
Lung sounds. (1984) (11)
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects (2016) (11)
SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis (2021) (11)
Antiretroviral treatment guidelines. (2003) (11)
Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali (2018) (11)
Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy (2019) (11)
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease. (1997) (11)
DNA Methylation of Telomere-Related Genes and Cancer Risk (2018) (10)
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis (2021) (10)
Molecular identification of Mycobacterium bovis from cattle and human host in Mali: expanded genetic diversity (2016) (10)
New antiretroviral drugs part I: PIs. (1999) (10)
Promoter methylation of PGC1A and PGC1B predicts cancer incidence in a veteran cohort. (2018) (10)
Impact of the COVID-19 pandemic on global health research training and education (2020) (9)
Signs and symptoms of "asymptomatic" HIV-1 infection in homosexual men. Multicenter AIDS Cohort Study. (1993) (9)
Stool microbiome reveals diverse bacterial ureases as confounders of oral urea breath testing for Helicobacter pylori and Mycobacterium tuberculosis in Bamako, Mali (2016) (9)
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects (2016) (9)
Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis (2019) (9)
Longitudinal Analysis of SARS-CoV-2 Vaccine Breakthrough Infections Reveals Limited Infectious Virus Shedding and Restricted Tissue Distribution (2022) (9)
Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection. (1996) (9)
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis (2021) (9)
A qualitative and quantitative survey of Forensic Medical Examiner workload in the Northumbria Police Force area October 2002-January 2003. (2006) (9)
Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes (2011) (9)
Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria (2017) (9)
HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects (2016) (8)
Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali (2019) (8)
Kaletra (Lopinavir/ritonavir) Therapy in Single Protease Inhibitor Experienced Patients: 144-Week Follow-up (2001) (8)
High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology (2014) (8)
Safety and Efficacy of zidovudine in asymptomatic HIV infected individuals withless than 500 CD4+ cells/mm3. (1990) (8)
Clinical and biological insights in HIV-associated cardiovascular disease in the era of highly active antiretroviral therapy. (2003) (8)
Comparison of auditory brainstem response in HIV-1 exposed and unexposed newborns and correlation with the maternal viral load and CD4+ cell counts (2014) (8)
Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 (2022) (8)
Reviving Protease Inhibitors: New Data and More Options (2003) (8)
Lung function after acute toluene di-isocyanate inhalation. (1973) (8)
State of the Art Lung Sounds 1 ’ 2 (2001) (8)
Development and clinical evaluation of a new multiplex PCR assay for a simultaneous diagnosis of tuberculous and nontuberculous mycobacteria (2021) (8)
Optimizing Treatment Switch for Virologic Failure during First-Line Antiretroviral Therapy in Resource-Limited Settings (2013) (8)
Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG. (2008) (8)
Clindamycin and primaquine as primary treatment for mild and moderately severePneumocystis carinii pneumonia in patients with AIDS (1991) (8)
Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians. (2011) (8)
A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection. (2016) (8)
Association of Mycobacterium africanum Infection with Slower Disease Progression Compared with Mycobacterium tuberculosis in Malian Patients with Tuberculosis (2019) (7)
Signs and symptoms of asymptomatic HIV-1 infection in homosexual men: Multicenter AIDS Cohort Study [comments]. (1994) (7)
New antiretroviral drugs in development. (2000) (7)
Dynamic Metrics for Public Health Surveillance Are Imperative to Gain Control of the COVID-19 Pandemic in America: Longitudinal Trend Analysis. (2020) (7)
Pharmacokinetics, protein‐binding‐adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment‐naïve HIV‐infected patients * (2010) (7)
Skin Test Reactivity and Cellular Immune Responses toMycobacterium avium Sensitin in AIDS Patients at Risk for Disseminated M. avium Infection (2001) (7)
Crackles in the Early Detection of Asbestosis1,2 (2015) (7)
European SARS-CoV-2 Surveillance: Longitudinal Trend Analyses of Wave Two. (2021) (7)
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients. (1989) (7)
Antiretroviral Therapy in Patients with Suboptimal Virologic Suppression (2001) (7)
The Interplay Between Policy and COVID-19 Outbreaks in South Asia: Longitudinal Trend Analysis of Surveillance Data (2020) (7)
A step ahead on the HIV collaboratory. (2009) (6)
HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis (2019) (6)
Performance of Screening for SARS-CoV-2 using Rapid Antigen Tests to Detect Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infection: findings from the Test Us at Home prospective cohort study (2022) (6)
Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis (2002) (6)
Extrapulmonary infection with Pneumocystis carinii in patients receiving aerosolized pentamidine. (1991) (6)
Latin America and the Caribbean SARS-CoV-2 Surveillance: Longitudinal Trend Analysis (2021) (6)
Missed Opportunities for Prevention of Mother-to-Child Transmission of HIV (PMTCT) in Ibadan, Southwest Nigeria (2014) (6)
The stethoscope--obsolescence or marriage. (2005) (6)
HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings. (2018) (6)
Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals (2022) (6)
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. (2000) (6)
Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions (2016) (6)
Clinical aspects of human immunodeficiency virus disease: clinical rationale for treatment. (1995) (5)
Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies (2021) (5)
High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali (2022) (5)
Acoustic findings in a patient with radiation pneumonitis. (2010) (5)
Connection Domain Mutations During Antiretroviral Treatment Failure in Mali: Frequencies and Impact on Reverse Transcriptase Inhibitor Activity (2012) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria (2018) (5)
Concurrent bacterial lung infection in patients with AIDS, PCP, and respiratory failure. (1992) (5)
Middle East and North Africa SARS-CoV-2 Surveillance: A Longitudinal Trend Analysis. (2020) (5)
The marriage of science and optimized HIV care in resource-limited settings. (2008) (5)
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali. (2019) (5)
Factors associated with changes in the use of antiretroviral therapy by a cohort of homosexual men infected with human immunodeficiency virus type 1. (1995) (5)
Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks. (1999) (5)
Virol . G . Pletnev Alexander A . Rumyantsev , Brian R . Murphy and Alexander Immunodeficient Mice Lacks Neuroinvasiveness for Restricted in Neuroblastoma Cells and Temperature Sensitive and Host Range A Tick-Borne Langat Virus Mutant (2006) (5)
Efavirenz and Lopinavir Levels in HIV-Infected Women and Their Nursing Infants, in Mali (2018) (5)
The Irish Border as a Customs Frontier after Brexit. CEPS Commentary, 11 July 2017 (2017) (5)
Introduction: Clinical infectious diseases (2000) (4)
Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: a systematic review. (2020) (4)
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. (2001) (4)
Diabetes Mellitus among new tuberculosis patients in Bamako, Mali (2019) (4)
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy (2022) (4)
PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF THE EFFECTS OF THREE MODERN ANTIRETROVIRAL THERAPIES ON CAROTID INTIMA-MEDIA THICKNESS IN HIV-INFECTED INDIVIDUALS (AIDS CLINICAL TRIALS GROUP STUDY A5260S) (2014) (4)
Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trial. (2010) (4)
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. (1994) (4)
Central Asia SARS-CoV-2 Surveillance: A Longitudinal Trend Analysis. (2021) (4)
p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies (2020) (4)
Extensively drug resistant tuberculosis in Mali: a case report (2017) (4)
Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali (2018) (4)
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali. (2017) (4)
Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings (2007) (3)
Systemic reaction to pyrimethamine-sulfadoxine. (1986) (3)
Immunovirological and Biochemical Changes in Nigerian Patients with Hepatitis B Coinfection on Antiretroviral Therapy (2011) (3)
Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV. (2019) (3)
Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali. (2018) (3)
East Asian and the Pacific Surveillance of SARS-CoV-2 Wave Two: Longitudinal Trend Analysis. (2021) (3)
Safety, pharmacokinetics, and efficacy of (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine with efavirenz and stavudine in antiretroviral-naïve human immunodeficiency virus-infected patients. (2005) (3)
Initiating antiretroviral therapy (1999) (3)
The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx Tech (2021) (3)
Acoustic biomarkers of Chronic Obstructive Lung Disease (2012) (3)
Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya. (2019) (3)
Developing Innovative Interdisciplinary Biomedical Engineering Programs in Nigeria: Lessons Learned (2016) (3)
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. (2002) (3)
Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions. (2020) (3)
Pulmonary function in shipyard welders: an epidemiologic study. (1973) (3)
HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults. (2017) (3)
Immunologic Reconstitution Through 6 Years in Antiretroviral-Naïve Subjects Treated with Lopinavir/ritonavir (LPV/r) (2005) (3)
Cleft palate in HIV-exposed newborns of mothers on highly active antiretroviral therapy (2014) (3)
Global Health Master’s Students: Demographics and Career Goals (2017) (3)
Antiretroviral Therapy: When to Start and What to Start (2005) (2)
Changing patterns in trend of top 10 cancers in the Jos University Teaching Hospital’s (JUTH) cancer registry (1996–2018), Jos, north-central Nigeria (2019) (2)
A Preprogram Appraisal of Factors Influencing Research Productivity among Faculty at College of Medicine, University of Lagos (2020) (2)
METHOD FOR DIFFERENTIAL DIAGNOSIS OF CENTRALLY AND PERIPHERALLY GENERATED WHEEZES (2009) (2)
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) (2018) (2)
Effect of Baseline Symptom Manifestations on Retention in Care and Treatment among HIV-Infected Patients in Nigeria (2020) (2)
AT-527, a pan-genotypic purine nucleotideprodrug, exhibits potent antiviral activity in subjects with chronic hepatitis C (2018) (2)
New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond. (1999) (2)
INDUCED DISEASE-DRUG, IRRADIATION, OCCUPATION (1981) (2)
Comparing Treatment Outcomes of Antiretroviral Therapy in HIV-1 and HIV-2 Infected Patients, in Bamako, Mali. (2018) (2)
From Creation to Evaluation: A Comprehensive Global Health Scholars Program for Graduate Medical Education Trainees (2020) (2)
Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis (2019) (2)
Virologic and CD 4 1 Cell Responses to New Nucleoside Regimens : Switching to Stavudine or Adding Lamivudine after Prolonged Zidovudine Treatment of Human Immunodeficiency Virus Infection (2004) (2)
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy (Preprint) (2020) (1)
Reply to Phillips (2005) (1)
Harnessing student involvement: Perspectives from building infrastructure for sexual harassment prevention and response at the University of Lagos, Nigeria (2022) (1)
Atypical cells in Pap Smears, an evaluation of proportions and possible risk factors at the Jos University Teaching Hospital, Nigeria. (2019) (1)
Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–2017 (2022) (1)
Activity and safety of stavudine (1997) (1)
High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology (2014) (1)
Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): a point-of-care PCR test for rapid detection of SARS-CoV-2 infection (2022) (1)
A Phase 1 b / 2 a study of the safety , pharmacokinetics and antiviral activity of BIT 225 in patients with HIV-1 infection (2016) (1)
Trends in Kaposi sarcoma prevalence at HIV care initiation in adults at a large HIV treatment program in Jos, Nigeria (2020) (1)
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) (2021) (1)
SARS-CoV-2 Surveillance System in Canada: Longitudinal Trend Analysis (Preprint) (2020) (1)
Telepathology in Nigeria for Global Health Collaboration (2022) (1)
Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. (2020) (1)
Myopathy associated with zidovudine use in HIV-1 infection (1992) (1)
Screening new tuberculosis patients in Mali for rifampicin resistance at 2 months (2016) (1)
Expedition report: MV Anne S. Pierce, 2000, German Bank, Scotian Shelf (2001) (1)
Educating an interprofessional workforce: evaluation of a competency-based MS in global health (2016) (1)
SARS-CoV-2 Surveillance System in Canada: Longitudinal Trend Analysis (2021) (1)
Gravity Dependence of Crackles (1983) (1)
Accelerated epigenetic age among HIV-infected Nigerian women with invasive cervical cancer. (2021) (1)
MECHANICALLY INDUCED INJURY IN SHEEP: CORRELATION OF MULTI-CHANNEL LUNG SOUND ANALYSIS AND PATHOLOGY (2007) (1)
Poor immune status and systemic disease are independently associated with mortality in AIDS-related Kaposi Sarcoma in Nigeria (2012) (1)
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali. (2020) (1)
Virologic and CD 4 Cell Response to Zidovudine or Zidovudine and Lamivudine Following Didanosine Treatment of Human Immunodeficiency Virus Infection (2004) (1)
Endothelial Function, Lipoproteins,and Cardiovascular Inflammatory Markers in Treated HIV-infected Patients with Hyperlipidemia Who Were Switched to an Atazanavir-containing Regimen or Continued on Other Protease Inhibitor-based Therapy: Switch to Atazanavir and Brachial Artery Reactivity Study (2009) (1)
Lung Sound Patterns in Common Pulmonary Disorder (2003) (1)
Supporting Diagnosis and Management of HIV/AIDS Patients Through Point-of-Care Technology Development. (2019) (1)
C-THAN: A new research center for the development of point-of-care technology for HIV/AIDS (2019) (1)
Finding a Needle in the Haystack: Design and Implementation of a Digital Site-less Clinical Study of Serial Rapid Antigen Testing to Identify Asymptomatic SARS-CoV-2 Infection (2022) (1)
Using Technology to Improve Quality of Cancer Care in Resource-Limited Settings (2019) (1)
Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates (2022) (1)
Future Directions and Potentials (1985) (1)
Regular meeting of the Sacramento-Yolo Port District Commission April 2, 2008 Closed Session Agenda (2008) (0)
CRACKLES IN PATIENTS WITH INTERSTITIAL PULMONARY FIBROSIS (2006) (0)
Crackle Variability In Patients With Pneumonia, Congestive Heart Failure, And Interstitial Pulmonary Fibrosis (2011) (0)
MECHANISM OF EXPIRATORY CRACKLES (2005) (0)
RATIO OF LOW FREQUENCY ENERGY TO HIGH FREQUENCY ENERGY OF LUNG SOUNDS IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE (2008) (0)
OPENING REMARKS AND WELCOME MESSAGES TO THE 40 th ANNUAL ILSA CONFERENCE (2015) (0)
Crackle Polarity is Influenced by Respiratory Cycle (2004) (0)
Chest Auscultation in Occupational Lung Disease (1986) (0)
PROLONGATION OF THE EXPIRATORY PHASE IN CHRONIC OBSTRUCTIVE LUNG DISEASE (2005) (0)
OCCUPATIONAL LUNG DISEASE: RESEARCH APPROACHES AND METHODS (Lung Biology in Health and Disease Series, Volume 18) (1983) (0)
ACOUSTIC CHARACTERISTICS OF PNEUMOTHORAX IN HUMANS (2007) (0)
ACCURACY OF INTERPRETATION OF COMPUTERIZED MULTICHANNEL LUNG SOUND ANALYSES (2008) (0)
lessons , future possibilities . Auscultation of the lung : past (0)
INTER-CHANNEL INHOMOGENEITY OF THE TIMING OF LUNG SOUNDS IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE (2008) (0)
Robert G. Loudon and Raymond L. H. Murphy (2001) (0)
supraclavicular space Transpulmonary speed of sound input into the (2015) (0)
Breath sound diagnostic apparatus (1979) (0)
CRACKLE RATE VARIABILITY IN PATIENTS WITH PNEUMONIA AND CHF AND IPF (2009) (0)
ACOUSTIC CHANGES IN PNEUMOTHORAX AND HEMOTHORAX (2007) (0)
Lung Sounds1,2 (2015) (0)
Aerosolized pentamidine prophylaxis following pneumocystis carinii pneumonia in patients with aids (1990) (0)
Stavudine and didanosine combination therapy in HIV-infected subjects Analysis of antiviral effect and safety in a randomized double-blind study (1997) (0)
Efficacy and Safety of Adefovir Dipivoxil With Antiretroviral Therapy (2017) (0)
SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis (Preprint) (2020) (0)
P3 Early evidence of antiviral activity and safety of ABX464 in HIV treatment-naïve patients (2016) (0)
Chapter 18. Intellectual Property Protection and Commercialisation (2019) (0)
Global line-1 hypomethylation as novel biomarker for cervical cancer in Nigerian women living with HIV. (2021) (0)
Infection in the Compromised Host (1992) (0)
Infection in the Compromised Host (1992) (0)
Erratum: Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection (Expert Opinion on Pharmacotherapy (2012) 13:1(65-79)) (2015) (0)
Clinician’s Manual on the Management of AIDS (1996) (0)
Performance Comparison of Xpert HIV-1 Viral Load Assay and Roche Taqman and Abbott M2000 RT in Bamako, Mali (2020) (0)
Chapter 13. Infant Warming Device for Neonatal Surgery in a Low-Resource Settings (2019) (0)
1208 BIT225, AN HCV-P7 INHIBITOR, WITH ENHANCED ANTI-HCV ACTIVITY IN COMBINATION WITH PEGYLATED INTERFERONalfa- 2b AND RIBAVIRIN IN HCV GENOTYPE-1 TREATMENT NAÏVE SUBJECTS: PHARMACOKINETIC AND RESISTANCE STUDIES (2013) (0)
CMV Retinitis is a Risk Factor for Mortality inPatients with AIDS in the Era of HAART (2004) (0)
Prevalence and Predictors of Cervical Cytological (Pap Smear) Abnormalities Among HIV-infected Women at the HIV Treatment Center of Jos University Teaching Hospital Jos, Nigeria. (2020) (0)
No evidence of fibrosis regression in HCV/HIV co-infected and HCV monoinfected participants up to 3 years after achieving SVR with DAA treatment: Interim results for the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) (2018) (0)
Master of Science in Global Health Students: Who Are They and What Jobs Do They Want? (2017) (0)
Diagnostic Performances of Three Rapid Diagnostic Tests for Detecting HIV Infections in Mali. (2019) (0)
UvA-DARE ( Digital Academic Repository ) Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV-1 (2017) (0)
Helminthic Infections in Pregnancy (1998) (0)
Abstract LB-235: DNA methylation of individual repetitive elements in HCV infection-induced HCC (2018) (0)
S182 Update on pneumocystosis (1997) (0)
Developing innovative and interdisciplinary global health training programs across all levels of medical education (2016) (0)
A new workforce for a new era: characteristics of Master of Science in Global Health students (2016) (0)
Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management. (2003) (0)
Safety, Pharmacokinetics, and Efﬁcacy of ( (cid:1) / (cid:2) )- (cid:3) -2 (cid:4) ,3 (cid:4) -Dideoxy-5-Fluoro-3 (cid:4) -Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naı¨ve Human Immunodeﬁciency Virus-Infected Patients (2005) (0)
Kaposi sarcoma among adults enrolling for HIV care in a large HIV clinic in Nigeria: 2006-2017. (2021) (0)
Clinical aspects of HIV infection and AIDS: prevention and treatment of opportunistic infections (1994) (0)
Comparison of Hearing Status of HIV-Exposed and -Unexposed Newborns and Immunovirologic Correlates in HIV-Exposed Newborns (2014) (0)
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali. (2020) (0)
Erratum to: Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria (2017) (0)
HIV and AIDS (2005) (0)
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children (2023) (0)
Developing and Refining the MSGH Degree Program: A Theory and Competency-Driven, Multi-Phase Curriculum Development and Alignment Process (2017) (0)
Predictors of Mortality From a Population-Based Cancer Registry Data in Jos, Nigeria: A Resource-Limited Setting (2020) (0)
Latin America and the Caribbean SARS-CoV-2 Surveillance: Longitudinal Trend Analysis (Preprint) (2020) (0)
Stavudine-based multiple agent combinations: initial studies and ongoing comparative trials. (1998) (0)
A review of stavudine (1996) (0)
The Postpartum Health Status of Women in an Urban Clinic in Santiago, Dominican Republic (2015) (0)
Efavirenz concentrations in HIV-infected Malian women and their nursing infants (2018) (0)
Abstract 1248.5: Lipoprotein Changes in HIV-Infected Antiretroviral-Naive Individuals after Starting Class-Sparing Antiretroviral Therapy: ACTG Study A5152s (2008) (0)
Abstract 64: The Prevalence of Hepatocellular Carcinoma in HIV-Infection: Results of Large-Scale Liver Ultrasound Screening Program in HIV-Infected Nigerians (2021) (0)
UvA-DARE ( Digital Academic Repository ) Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV (2004) (0)
Use of Appropriate Technology to Improve Cervical Cancer Prevention and Early Detection: Experience in Jos, Nigeria (2019) (0)
HIV AIDS Infections. Handbooks in Healthcare. (1997) (0)
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis (Preprint) (2020) (0)
Amprenavir and Fosamprenavir (2010) (0)
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS) (2023) (0)
Corticosteroids, Cytotoxic Agents and Infection (1996) (0)
Abstract 83: Blood-Based Circulating Cell-Free DNA Epigenetic Age Is Accelerated Among HIV-Infected Patients with Hepatocellular Carcinoma in Nigeria (2021) (0)
SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis (Preprint) (2020) (0)
ImpactofHepatitisCVirusonHIVResponsetoAntiretroviral Therapy in Nigeria (2013) (0)
Use of sodium dodecyl sulfate to improve tuberculosis sputum smear microscopy (2019) (0)
Acceleration of blood-based circulating cell-free DNA epigenetic age among HIV-infected patients with hepatocellular carcinoma in Nigeria. (2021) (0)
Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study (Preprint) (2020) (0)
Is there any relationship between hearing threshold levels and CD4 cell count of human immunodeficiency virus infected adults? (2016) (0)
Erratum to: Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV (2010) (0)
DAPSONE FOR PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH HIV INFECTION ATOVAQUONE COMPARED WITH DAPSONE FOR THE PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH HIV INFECTION WHO CANNOT TOLERATE TRIMETHOPRIM , SULFONAMIDES (2017) (0)
HIV and development of epithelial cell abnormalities in women with prior normal cervical cytology in Nigeria (2020) (0)
TP53 p.Arg72Pro polymorphism and Breast Cancer Risk: A meta-analysis of case-control studies (2020) (0)
Genetic studies on the IL-4 cluster in atopic and parasitised populations. (2005) (0)
The problem of resistance in Mycobacterium tuberculosis may be underestimated in Africa (2018) (0)
Outcomes for therapeutic vaccines trials (2006) (0)
Genetic variation in human IL10 proximal promoter and susceptibility to HIV-1 infection in Mali, West Africa. (2020) (0)
Arg72Pro polymorphism in P53 gene and Breast Cancer Risk Population: a meta-analysis of case-control studies matched (2019) (0)
Findings of Feasibility for Serial Testing Using Over-the-Counter SARS-CoV-2 Test with the Assistance of a Digital Smartphone App (Preprint) (2021) (0)
Feasibility of At-Home Serial Testing Using Over-the-Counter SARS-CoV-2 Tests With a Digital Smartphone App for Assistance: Longitudinal Cohort Study (2021) (0)
HBV co-infection is associated with persistently elevated liver stiffness measurement in HIV-positive adults: A 6-year single-centre cohort study in Nigeria (2021) (0)
Short Communication: Genetic Variation in Human IL10 Proximal Promoter and Susceptibility to HIV-1 Infection in Mali, West Africa (2020) (0)
Abstract 76: Global LINE-1 Hypomethylation as Novel Biomarker for Cervical Cancer in Nigerian Women Living with HIV (2021) (0)
Lack of Association of C677T Methylenetetrahydrofolate Reductase Polymorphism with Breast Cancer Risk in Mali (2023) (0)
Abstract 71: Accelerated Epigenetic Age among HIV-infected Nigerian Women with Invasive Cervical Cancer (2021) (0)
Abstract 3021: Epigenetic signatures of virus-associated cervical cancer in women living with HIV (2023) (0)
Association of the Interleukin-10-592C/A Polymorphism and Cervical Cancer Risk: A Meta-Analysis (2022) (0)
Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–2017 (2022) (0)
Performance of Rapid Antigen Tests Based on Symptom Onset and Close Contact Exposure: A secondary analysis from the Test Us At Home prospective cohort study (2023) (0)
HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis (2019) (0)
Overlapping Delta and Omicron Outbreaks: Dynamic Panel Data. (2022) (0)
Sustaining the momentum for global cancer research and career development in the COVID-19 era: Lessons and challenges (2023) (0)
Abstract 32: Characteristics of Hepatocellular Carcinoma in Nigerians with and without HIV (2021) (0)
Sex Differences in Active Pulmonary Tuberculosis Outcomes in Mali, West Africa. (2022) (0)
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma (2019) (0)
Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria (2017) (0)
Abstract 6013: DNA methylation-based inflammation score is associated with hepatocellular carcinoma among people living with HIV (2023) (0)
Cervical cancer survival in a resource-limited setting-North Central Nigeria (2016) (0)
Accelerated Epigenetic Age Among Women with Invasive Cervical Cancer and HIV-Infection in Nigeria (2022) (0)
Saving Our Sons: The Impact of a Single Gender Public School on the Social, Emotional and Academic Progress of Young African American Males from Low Socioeconomic Urban Neighborhoods (2013) (0)
Erratum to: Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria (2017) (0)
Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection (2022) (0)
HIV and development of epithelial cell abnormalities in women with prior normal cervical cytology in Nigeria (2020) (0)
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV (2023) (0)
The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials (2022) (0)
Hepatitis B Virus in West African Children: Systematic Review and Meta-Analysis of HIV and Other Factors Associated with Hepatitis B Infection (2023) (0)
Prevalence and Clinical Relevance of Schistosoma mansoni Co-Infection with Mycobacterium tuberculosis: A Systematic Literature Review (2023) (0)
Diagnostic Laboratories' Capacities and Preparedness for Emerging Viral Diseases in Guinea and Mali. (2020) (0)
Molecular epidemiology and genetic diversity of Mycobacterium tuberculosis complex in referral health centers of Bamako, Mali: What is new? (2022) (0)
Extensively drug resistant tuberculosis in Mali: a case report (2017) (0)
ラベル貼りヘッド、断片の切り取り及びそれへのラベル貼り装置及び方法、並びに、ラベル張り付け方法 (2001) (0)
Apparatus and method for labeling a stack of flat material (2001) (0)
Expedition report: MV Hamilton Banker, 1999, Georges Bank, Gulf of Maine (2000) (0)
CBEO:N, Chesapeake Bay Environmental Observatory as a Cyberinfrastructure Node (2008) (0)
Crackle Pitch Rises Progressively During Inspiration In IPF, CHF, And Pneumonia Patients (2012) (0)

This paper list is powered by the following services:

Other Resources About Robert L. Murphy

What Schools Are Affiliated With Robert L. Murphy?

Robert L. Murphy is affiliated with the following schools:

Robert L. Murphy's Academic­Influence.com Rankings